A Colombian pharmaceutical company accuses its U.S. partner in Miami federal court of forcing it into an antitrust situation with its recent purchase of a European competitor.
Drug company wants partner to divest itself of recently acquired competitor
Daily Business Review
December 21, 2012
This article requires premium access
This article requires premium access to Daily Business Review. Please sign in or subscribe to read the full text.